78 related articles for article (PubMed ID: 3930637)
1. Immunoradiometric assay to measure the binding of a specific inhibitor to tissue-type plasminogen activator.
Schleef RR; Sinha M; Loskutoff DJ
J Lab Clin Med; 1985 Oct; 106(4):408-15. PubMed ID: 3930637
[TBL] [Abstract][Full Text] [Related]
2. Detection of both type 1 and type 2 plasminogen activator inhibitors in human cells.
Schleef RR; Wagner NV; Loskutoff DJ
J Cell Physiol; 1988 Feb; 134(2):269-74. PubMed ID: 3257967
[TBL] [Abstract][Full Text] [Related]
3. Kinetic analysis of the interactions between plasminogen activator inhibitor 1 and both urokinase and tissue plasminogen activator.
Hekman CM; Loskutoff DJ
Arch Biochem Biophys; 1988 Apr; 262(1):199-210. PubMed ID: 3128176
[TBL] [Abstract][Full Text] [Related]
4. Binding of type 1 plasminogen activator inhibitor to the extracellular matrix of cultured bovine endothelial cells.
Mimuro J; Loskutoff DJ
J Biol Chem; 1989 Mar; 264(9):5058-63. PubMed ID: 2494180
[TBL] [Abstract][Full Text] [Related]
5. Extracellular matrix of cultured bovine aortic endothelial cells contains functionally active type 1 plasminogen activator inhibitor.
Mimuro J; Schleef RR; Loskutoff DJ
Blood; 1987 Sep; 70(3):721-8. PubMed ID: 3113515
[TBL] [Abstract][Full Text] [Related]
6. Dexamethasone inhibition of tissue-type plasminogen activator (tPA) activity: paradoxical induction of both tPA antigen and plasminogen activator inhibitor.
Gelehrter TD; Sznycer-Laszuk R; Zeheb R; Cwikel BJ
Mol Endocrinol; 1987 Jan; 1(1):97-101. PubMed ID: 3137452
[TBL] [Abstract][Full Text] [Related]
7. A monoclonal antibody that does not recognize tissue-type plasminogen activator bound to its naturally occurring inhibitor.
Schleef RR; Wagner NV; Sinha M; Loskutoff DJ
Thromb Haemost; 1986 Dec; 56(3):328-32. PubMed ID: 2436333
[TBL] [Abstract][Full Text] [Related]
8. Cytokine activation of vascular endothelium. Effects on tissue-type plasminogen activator and type 1 plasminogen activator inhibitor.
Schleef RR; Bevilacqua MP; Sawdey M; Gimbrone MA; Loskutoff DJ
J Biol Chem; 1988 Apr; 263(12):5797-803. PubMed ID: 3128548
[TBL] [Abstract][Full Text] [Related]
9. Bleeding diathesis due to decreased functional activity of type 1 plasminogen activator inhibitor.
Schleef RR; Higgins DL; Pillemer E; Levitt LJ
J Clin Invest; 1989 May; 83(5):1747-52. PubMed ID: 2496147
[TBL] [Abstract][Full Text] [Related]
10. Interaction between plasminogen activator inhibitor type 1 (PAI-1) bound to fibrin and either tissue-type plasminogen activator (t-PA) or urokinase-type plasminogen activator (u-PA). Binding of t-PA/PAI-1 complexes to fibrin mediated by both the finger and the kringle-2 domain of t-PA.
Wagner OF; de Vries C; Hohmann C; Veerman H; Pannekoek H
J Clin Invest; 1989 Aug; 84(2):647-55. PubMed ID: 2503541
[TBL] [Abstract][Full Text] [Related]
11. Binding of tissue plasminogen activator to human aortic endothelial cells.
Sanzo MA; Howard SC; Wittwer AJ; Cochrane HM
Biochem J; 1990 Jul; 269(2):475-82. PubMed ID: 2117440
[TBL] [Abstract][Full Text] [Related]
12. Prostaglandin E2 regulates production of plasminogen activator isoenzymes, urokinase receptor, and plasminogen activator inhibitor-1 in primary cultures of rat calvarial osteoblasts.
Allan EH; Martin TJ
J Cell Physiol; 1995 Dec; 165(3):521-9. PubMed ID: 7593231
[TBL] [Abstract][Full Text] [Related]
13. Purification of an active plasminogen activator inhibitor immunologically related to the endothelial type plasminogen activator inhibitor from the conditioned media of a human melanoma cell line.
Wagner OF; Vetterlein M; Binder BR
J Biol Chem; 1986 Nov; 261(31):14474-81. PubMed ID: 3490474
[TBL] [Abstract][Full Text] [Related]
14. Identification of the binding site for a low-molecular-weight inhibitor of plasminogen activator inhibitor type 1 by site-directed mutagenesis.
Björquist P; Ehnebom J; Inghardt T; Hansson L; Lindberg M; Linschoten M; Strömqvist M; Deinum J
Biochemistry; 1998 Feb; 37(5):1227-34. PubMed ID: 9477948
[TBL] [Abstract][Full Text] [Related]
15. A molecular variant of plasminogen activator inhibitor of rat decidual tissue.
Tarachand U; Pawse AR
Biochem Mol Biol Int; 1995 Dec; 37(6):1037-45. PubMed ID: 8747533
[TBL] [Abstract][Full Text] [Related]
16. TM5275 prolongs secreted tissue plasminogen activator retention and enhances fibrinolysis on vascular endothelial cells.
Yasui H; Suzuki Y; Sano H; Suda T; Chida K; Dan T; Miyata T; Urano T
Thromb Res; 2013 Jul; 132(1):100-5. PubMed ID: 23611258
[TBL] [Abstract][Full Text] [Related]
17. The plasminogen activator inhibitor-1 binding site in the kringle-2 domain of tissue-type plasminogen activator.
Kaneko M; Mimuro J; Matsuda M; Sakata Y
Biochem Biophys Res Commun; 1991 Aug; 178(3):1160-6. PubMed ID: 1908232
[TBL] [Abstract][Full Text] [Related]
18. Biological mechanisms underlying the clinical effects of RU 486: modulation of cultured endometrial stromal cell plasminogen activator and plasminogen activator inhibitor expression.
Lockwood CJ; Krikun G; Papp C; Aigner S; Schatz F
J Clin Endocrinol Metab; 1995 Apr; 80(4):1100-5. PubMed ID: 7714076
[TBL] [Abstract][Full Text] [Related]
19. Inactivation of plasminogen activator inhibitor by oxidants.
Lawrence DA; Loskutoff DJ
Biochemistry; 1986 Oct; 25(21):6351-5. PubMed ID: 3098287
[TBL] [Abstract][Full Text] [Related]
20. Progestin inhibits and thrombin stimulates the plasminogen activator/inhibitor system in term decidual stromal cells: implications for parturition.
Norwitz ER; Snegovskikh V; Schatz F; Foyouzi N; Rahman M; Buchwalder L; Lee HJ; Funai EF; Buhimschi CS; Buhimschi IA; Lockwood CJ
Am J Obstet Gynecol; 2007 Apr; 196(4):382.e1-8. PubMed ID: 17403427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
